SCHEMBL7893294

SCHEMBL7893294

OC1CC2CC(Cc3ccccn3)C1C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
P2RX7 Q99572 1/20 0.37
HSD11B1 P28845 3/20 0.36
LTB4R Q15722 1/20 0.36
LTB4R2 Q9NPC1 1/20 0.36
GLS O94925 1/20 0.36
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
DRD2 P14416 1/20 0.35
CHRM3 P20309 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HRH1 P35367 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984252 0.75 KDM4E (0.40) ALDH1A1KDM4ELTB4RLTB4R2GLS
SCHEMBL7893260 0.74 ALDH1A1 (0.40) ALDH1A1KDM4EP2RX7HSD11B1GLS
SCHEMBL7893289 0.74 KDM4E (0.39) ALDH1A1KDM4EP2RX7HSD11B1LTB4R
SCHEMBL28953834 0.73 HPGD (0.43) GLSSMN1; SMN2
SCHEMBL29950596 0.73 HPGD (0.43) GLSSMN1; SMN2
SCHEMBL11541056 0.72 CYP19A1 (0.40) LTB4RLTB4R2CHRM2CHRM4CHRM5
SCHEMBL11541050 0.72 CYP19A1 (0.40) LTB4RLTB4R2CHRM2CHRM4CHRM5
SCHEMBL11541062 0.72 CYP19A1 (0.40) LTB4RLTB4R2CHRM2CHRM4CHRM5
SCHEMBL8091807 0.72 HRH3 (0.43) ALDH1A1LTB4RLTB4R2KDM1AMAOA
SCHEMBL16269835 0.72 HRH3 (0.43) ALDH1A1LTB4RLTB4R2KDM1AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900204-A4 HETEROCYCLIC COMPOUNDS LILLY CO ELI (US) 2001-03-21 EP disclosed
US-6124312-A ACTIVE DRUG FOR TREATING ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 2000-09-26 US disclosed
EP-0900204-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1999-03-10 EP disclosed
WO-1997040016-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1997-10-30 WO disclosed